E-LIB Suche - Ergebnisse für: De Haven Brandon, Alexis

1

Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells..:

Linardopoulos, Spiros ; Taussig, David C. ; Eccles, Suzanne A....
Blood Advances. 4 (2020) 7 - p. 1478-1491 , 2020

Link: https://doi.org/10.1182/..

2

Correction: Signalling involving MET and FAK supports cell ..:

Zhang, Chi ; Stockwell, Simon R. ; Elbanna, May...
Oncogene. 39 (2020) 16 - p. 3411-3412 , 2020

Link: https://doi.org/10.1038/..

3

Orally bioavailable CDK9/2 inhibitor shows mechanism-based ..:

Poon, Evon ; Liang, Tong ; Jamin, Yann...
Journal of Clinical Investigation. 130 (2020) 11 - p. 5875-5892 , 2020

Link: https://doi.org/10.1172/..

4

Combined targeting of MEK and the glucocorticoid receptor f..:

Sriskandarajah, Priya ; De Haven Brandon, Alexis ; MacLeod, Kenneth...
BMC Cancer. 20 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

5

Identification of ovarian high-grade serous carcinoma cell ..:

De Haven Brandon, Alexis ; Box, Gary ; Hallsworth, Albert...
Scientific Reports. 10 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

6

Correction: Suppression of interferon gene expression overc..:

Wagner, Steve ; Vlachogiannis, Georgios ; De Haven Brandon, Alexis...
Oncogene. 38 (2019) 28 - p. 5746-5746 , 2019

Link: https://doi.org/10.1038/..

7

Signalling involving MET and FAK supports cell division ind..:

Zhang, Chi ; Stockwell, Simon R. ; Elbanna, May...
Oncogene. 38 (2019) 30 - p. 5905-5920 , 2019

Link: https://doi.org/10.1038/..

8

Suppression of interferon gene expression overcomes resista..:

Wagner, Steve ; Vlachogiannis, Georgios ; De Haven Brandon, Alexis...
Oncogene. 38 (2018) 10 - p. 1717-1733 , 2018

Link: https://doi.org/10.1038/..

9

Introduction of a Methyl Group Curbs Metabolism of Pyrido[3..:

Woodward, Hannah L. ; Innocenti, Paolo ; Cheung, Kwai-Ming J....
Journal of Medicinal Chemistry. 61 (2018) 18 - p. 8226-8240 , 2018

Link: https://doi.org/10.1021/..

10

Discovery of Potent, Selective, and Orally Bioavailable Sma..:

Mallinger, Aurélie ; Schiemann, Kai ; Rink, Christian...
Journal of Medicinal Chemistry. 59 (2016) 3 - p. 1078-1101 , 2016

Link: https://doi.org/10.1021/..

11

Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Mo..:

Innocenti, Paolo ; Woodward, Hannah L. ; Solanki, Savade...
Journal of Medicinal Chemistry. 59 (2016) 8 - p. 3671-3688 , 2016

Link: https://doi.org/10.1021/..

12

Assessing the mechanism and therapeutic potential of modula..:

Clarke, Paul A ; Ortiz-Ruiz, Maria-Jesus ; TePoele, Robert...
eLife. 5 (2016) - p. , 2016

Link: https://doi.org/10.7554/..

13

Discovery of Potent, Orally Bioavailable, Small-Molecule In..:

Mallinger, Aurélie ; Crumpler, Simon ; Pichowicz, Mark...
Journal of Medicinal Chemistry. 58 (2015) 4 - p. 1717-1735 , 2015

Link: https://doi.org/10.1021/..

14

Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3,..:

Naud, Sébastien ; Westwood, Isaac M. ; Faisal, Amir...
Journal of Medicinal Chemistry. 56 (2013) 24 - p. 10045-10065 , 2013

Link: https://doi.org/10.1021/..

15

Combining TRAIL with PI3 Kinase or HSP90 inhibitors enhance..:

Saturno, Grazia ; Valenti, Melanie ; De Haven Brandon, Alexis...
Oncotarget. 4 (2013) 8 - p. 1185-1198 , 2013

Link: https://doi.org/10.18632..